Nuveen’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Buy
70,369
+22,849
+48% +$123K ﹤0.01% 3030
2025
Q4
$377K Hold
47,520
﹤0.01% 2978
2025
Q3
$163K Hold
47,520
﹤0.01% 3190
2025
Q2
$196K Sell
47,520
-16,583
-26% -$55.3K ﹤0.01% 3164
2025
Q1
$154K Hold
64,103
﹤0.01% 3163
2024
Q4
$233K Hold
64,103
﹤0.01% 3180
2024
Q3
$404K Hold
64,103
﹤0.01% 3083
2024
Q2
$428K Buy
+64,103
New +$379K ﹤0.01% 3044
2023
Q4
Sell
-115,145
Closed -$388K 3348
2023
Q3
$388K Sell
115,145
-31,404
-21% -$206K ﹤0.01% 2917
2023
Q2
$1.21M Buy
146,549
+18,020
+14% +$162K ﹤0.01% 2570
2023
Q1
$1.12M Buy
128,529
+25,366
+25% +$282K ﹤0.01% 2568
2022
Q4
$1.26M Buy
103,163
+12,450
+14% +$118K ﹤0.01% 2591
2022
Q3
$577K Sell
90,713
-1,219
-1% -$10.3K ﹤0.01% 2932
2022
Q2
$826K Buy
91,932
+52,037
+130% +$458K ﹤0.01% 2876
2022
Q1
$599K Buy
39,895
+25,579
+179% +$394K ﹤0.01% 2959
2021
Q4
$272K Hold
14,316
﹤0.01% 3192
2021
Q3
$327K Buy
+14,316
New +$471K ﹤0.01% 3239

Other funds holding SGHT

Nuveen's SGHT Position: Q1 2026 in Review

Nuveen increased its Sight Sciences (SGHT) stake by 48% in Q1 2026, buying an estimated $123K and bringing the position to 70,369 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #3030.

Nuveen first reported a position in SGHT in Q3 2021 and has held it in 17 quarters since. The position peaked at $1.26M in Q4 2022. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Nuveen held 70,369 shares of Sight Sciences worth $265K as of Q1 2026.
  • Nuveen bought 22,849 Sight Sciences shares in Q1 2026, an estimated $123K.
  • Sight Sciences made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #3030 holding.
  • Nuveen first reported a position in Sight Sciences in Q3 2021 and has held it in 17 quarters since.
  • Nuveen's Sight Sciences position peaked at $1.26M in Q4 2022.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.